---
schema_version: "secwatch.filing_event.v1"
accession: "0001819790-25-000035"
form_type: "8-K"
ticker: "TARS"
cik: "0001819790"
company_name: "Tarsus Pharmaceuticals, Inc."
filed_at: "2025-03-18T23:59:59+00:00"
generated_at: "2026-05-24T14:18:18.874494+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tarsus closes public offering of 3.23M shares; net proceeds $134.8M

## Summary
- Underwriters exercised full over-allotment; total shares sold: 3,230,336 (incl. 421,348 additional shares).
- Shares sold to underwriters at $41.83 each; public offering price $44.50.
- Net proceeds of ~$134.8M after underwriting discounts and estimated offering expenses.
- Offering closed on March 14, 2025; use of proceeds not specified but typical for general corporate purposes.

## SEC filing metadata
- accession: 0001819790-25-000035
- form_type: 8-K
- ticker: TARS
- cik: 0001819790
- company_name: Tarsus Pharmaceuticals, Inc.
- filed_at: 2025-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1819790/000181979025000035/0001819790-25-000035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1819790/000181979025000035/tars-20250314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001819790-25-000035
- JSON: https://secwatch.observer/filing/0001819790-25-000035.json
- Plain text: https://secwatch.observer/filing/0001819790-25-000035.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.